Clinical Trial Update: A Phase II Trial Evaluating Irinotecan Plus 5FU/LV in Patients With Relapsed/Refractory Upper GI Tumours [Phase 2]

View source ↗

Summary

A Phase II trial evaluating irinotecan plus 5-fluorouracil with leucovorin in patients with relapsed or refractory upper gastrointestinal cancers has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Upper Gastrointestinal Cancer

Drugs mentioned

• 5-Fluorouracil (5-FU)
• Irinotecan (Irinotecan)
• Leucovorin (folinic acid)

Snippet

Sponsor: Royal Marsden NHS Foundation Trust | Conditions: Upper Gastrointestinal Tumours | Phase 2 | Status: COMPLETED